PROMIS and legacy measures compared in a supportive care intervention for breast cancer patients and caregivers: Experience from a randomized trial

Alla Sikorskii, David Victorson, Patrick O'Connor, Vered Hankin, Abolfazl Safikhani, Tracy Crane, Terry A Badger, Gwen Wyatt

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objective: Accurate and efficient measurement of patient-reported outcomes is key in cancer symptom management trials. The newer Patient Reported Outcomes Measurement Information System (PROMIS) and previously developed measures of similar conceptual content (legacy) are available to measure symptoms and functioning. This report compares the performance of two sets of measures, PROMIS and legacy, in a recently completed trial of a supportive care intervention that enrolled breast cancer patients and their friend or family caregivers. Methods: Patient-caregiver dyads (N = 256) were randomized to either reflexology delivered by caregivers or usual care control. Post-intervention, PROMIS and legacy measures of symptoms and functioning were analyzed in relation to trial arm, while adjusting for baseline values. Responsiveness of the two sets of measures was assessed using effect sizes and P-values for the effect of trial arm on patients' and caregivers' symptom and functioning outcomes. Results: Similar conclusions about intervention effects were found using PROMIS and legacy measures for pain, fatigue, sleep, anxiety, physical, and social functioning. Different conclusions were obtained for patient and caregiver depression: legacy measures indicated the efficacy of reflexology, while PROMIS depression measure did not. Conclusion: Evidence of similar responsiveness supports the use of either set of measures for symptoms and functioning in clinical and general populations. Differences between PROMIS and legacy measures of depression need to be considered when choosing instruments for use in trials of supportive care interventions and in clinical practice.

Original languageEnglish (US)
JournalPsycho-Oncology
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Information Systems
Caregivers
Breast Neoplasms
Massage
Depression
Patient Reported Outcome Measures
Fatigue
Sleep
Anxiety
Pain
Population
Neoplasms

Keywords

  • Cancer
  • Legacy measures
  • Measurement
  • PROMIS
  • Symptom management

ASJC Scopus subject areas

  • Experimental and Cognitive Psychology
  • Oncology
  • Psychiatry and Mental health

Cite this

PROMIS and legacy measures compared in a supportive care intervention for breast cancer patients and caregivers : Experience from a randomized trial. / Sikorskii, Alla; Victorson, David; O'Connor, Patrick; Hankin, Vered; Safikhani, Abolfazl; Crane, Tracy; Badger, Terry A; Wyatt, Gwen.

In: Psycho-Oncology, 01.01.2018.

Research output: Contribution to journalArticle

Sikorskii, Alla ; Victorson, David ; O'Connor, Patrick ; Hankin, Vered ; Safikhani, Abolfazl ; Crane, Tracy ; Badger, Terry A ; Wyatt, Gwen. / PROMIS and legacy measures compared in a supportive care intervention for breast cancer patients and caregivers : Experience from a randomized trial. In: Psycho-Oncology. 2018.
@article{51c525c23926445a9412f4a043ca2033,
title = "PROMIS and legacy measures compared in a supportive care intervention for breast cancer patients and caregivers: Experience from a randomized trial",
abstract = "Objective: Accurate and efficient measurement of patient-reported outcomes is key in cancer symptom management trials. The newer Patient Reported Outcomes Measurement Information System (PROMIS) and previously developed measures of similar conceptual content (legacy) are available to measure symptoms and functioning. This report compares the performance of two sets of measures, PROMIS and legacy, in a recently completed trial of a supportive care intervention that enrolled breast cancer patients and their friend or family caregivers. Methods: Patient-caregiver dyads (N = 256) were randomized to either reflexology delivered by caregivers or usual care control. Post-intervention, PROMIS and legacy measures of symptoms and functioning were analyzed in relation to trial arm, while adjusting for baseline values. Responsiveness of the two sets of measures was assessed using effect sizes and P-values for the effect of trial arm on patients' and caregivers' symptom and functioning outcomes. Results: Similar conclusions about intervention effects were found using PROMIS and legacy measures for pain, fatigue, sleep, anxiety, physical, and social functioning. Different conclusions were obtained for patient and caregiver depression: legacy measures indicated the efficacy of reflexology, while PROMIS depression measure did not. Conclusion: Evidence of similar responsiveness supports the use of either set of measures for symptoms and functioning in clinical and general populations. Differences between PROMIS and legacy measures of depression need to be considered when choosing instruments for use in trials of supportive care interventions and in clinical practice.",
keywords = "Cancer, Legacy measures, Measurement, PROMIS, Symptom management",
author = "Alla Sikorskii and David Victorson and Patrick O'Connor and Vered Hankin and Abolfazl Safikhani and Tracy Crane and Badger, {Terry A} and Gwen Wyatt",
year = "2018",
month = "1",
day = "1",
doi = "10.1002/pon.4825",
language = "English (US)",
journal = "Psycho-Oncology",
issn = "1057-9249",
publisher = "John Wiley and Sons Ltd",

}

TY - JOUR

T1 - PROMIS and legacy measures compared in a supportive care intervention for breast cancer patients and caregivers

T2 - Experience from a randomized trial

AU - Sikorskii, Alla

AU - Victorson, David

AU - O'Connor, Patrick

AU - Hankin, Vered

AU - Safikhani, Abolfazl

AU - Crane, Tracy

AU - Badger, Terry A

AU - Wyatt, Gwen

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Objective: Accurate and efficient measurement of patient-reported outcomes is key in cancer symptom management trials. The newer Patient Reported Outcomes Measurement Information System (PROMIS) and previously developed measures of similar conceptual content (legacy) are available to measure symptoms and functioning. This report compares the performance of two sets of measures, PROMIS and legacy, in a recently completed trial of a supportive care intervention that enrolled breast cancer patients and their friend or family caregivers. Methods: Patient-caregiver dyads (N = 256) were randomized to either reflexology delivered by caregivers or usual care control. Post-intervention, PROMIS and legacy measures of symptoms and functioning were analyzed in relation to trial arm, while adjusting for baseline values. Responsiveness of the two sets of measures was assessed using effect sizes and P-values for the effect of trial arm on patients' and caregivers' symptom and functioning outcomes. Results: Similar conclusions about intervention effects were found using PROMIS and legacy measures for pain, fatigue, sleep, anxiety, physical, and social functioning. Different conclusions were obtained for patient and caregiver depression: legacy measures indicated the efficacy of reflexology, while PROMIS depression measure did not. Conclusion: Evidence of similar responsiveness supports the use of either set of measures for symptoms and functioning in clinical and general populations. Differences between PROMIS and legacy measures of depression need to be considered when choosing instruments for use in trials of supportive care interventions and in clinical practice.

AB - Objective: Accurate and efficient measurement of patient-reported outcomes is key in cancer symptom management trials. The newer Patient Reported Outcomes Measurement Information System (PROMIS) and previously developed measures of similar conceptual content (legacy) are available to measure symptoms and functioning. This report compares the performance of two sets of measures, PROMIS and legacy, in a recently completed trial of a supportive care intervention that enrolled breast cancer patients and their friend or family caregivers. Methods: Patient-caregiver dyads (N = 256) were randomized to either reflexology delivered by caregivers or usual care control. Post-intervention, PROMIS and legacy measures of symptoms and functioning were analyzed in relation to trial arm, while adjusting for baseline values. Responsiveness of the two sets of measures was assessed using effect sizes and P-values for the effect of trial arm on patients' and caregivers' symptom and functioning outcomes. Results: Similar conclusions about intervention effects were found using PROMIS and legacy measures for pain, fatigue, sleep, anxiety, physical, and social functioning. Different conclusions were obtained for patient and caregiver depression: legacy measures indicated the efficacy of reflexology, while PROMIS depression measure did not. Conclusion: Evidence of similar responsiveness supports the use of either set of measures for symptoms and functioning in clinical and general populations. Differences between PROMIS and legacy measures of depression need to be considered when choosing instruments for use in trials of supportive care interventions and in clinical practice.

KW - Cancer

KW - Legacy measures

KW - Measurement

KW - PROMIS

KW - Symptom management

UR - http://www.scopus.com/inward/record.url?scp=85050946768&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050946768&partnerID=8YFLogxK

U2 - 10.1002/pon.4825

DO - 10.1002/pon.4825

M3 - Article

C2 - 29956396

AN - SCOPUS:85050946768

JO - Psycho-Oncology

JF - Psycho-Oncology

SN - 1057-9249

ER -